Retrospective Study to Review Patients at Risk for VTE at Hospital Discharge

An investigator initiated study exploring VTE prophylaxis at the time of hospital discharge.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Venous Thromboembolism Cardiovascular Diseases Embolism and Thrombosis Thromboembolism Vascular Diseases

Age range

17 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

It appears likely that many patients will remain at risk for VTE at the time of hospital discharge. These risks will go unrecognized, and discharge prophylaxis orders will not be prescribed.

To test this hypothesis, we will perform a retrospective review of approximately 2,500 patients at Brigham and Women's Hospital at risk for VTE at the time of hospital discharge to determine what proportion received VTE prophylaxis. We will correlate the implementation of discharge VTE prophylaxis with the occurrence of symptomatic DVT and pulmonary embolism within 90 days of hospital discharge.

We will also conduct a substudy of this patient population to determine adherence to VTE prophylaxis among hospitalized patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Acutely ill medical and surgical patients with a risk score of 4 or greater without prophylaxis or a risk score of 4 or greater with anticoagulation at hospital discharge.

Exclusion criteria

None.

Treatment and study plan

Primary outcomes

Symptomatic PE/DVT within 90 days of hospital discharge.

Time frame: 90 days

Sponsors and collaborators

Lead sponsor

Brigham and Women's Hospital

Other

Collaborators

Sanofi

Registry information

Official study title

VTE Prophylaxis Across the Continuum of Care: High Risk Patients at Hospital Discharge

Important dates

Study start: 2008
Primary completion: 2010
Study completion: 2011
First posted: Jan 30, 2008
Registry last updated: Feb 10, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed